Nobuhiko Uoshima

Years Active: 2023-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Kinuko Mitani, Jong Wook Lee, Jun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, Koji Nagafuji, Kensuke Usuki, Nobuhiko Uoshima, Tomoaki Fujisaki, Hiroshi Kosugi, Itaru Matsumura, Ko Sasaki, Masahiro Kizaki, Masashi Sawa, Michihiro Hidaka, Naoki Kobayashi, Satoshi Ichikawa, Yuji Yonemura, Kenta Murotani, Mami Shimizu, Akira Matsuda, Keiya Ozawa, Shinji Nakao
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study. Blood advances 8 (6) (2024)
Kinuko Mitani, Jong Wook Lee, Jun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, Koji Nagafuji, Kensuke Usuki, Nobuhiko Uoshima, Tomoaki Fujisaki, Hiroshi Kosugi, Itaru Matsumura, Ko Sasaki, Masahiro Kizaki, Masashi Sawa, Michihiro Hidaka, Naoki Kobayashi, Satoshi Ichikawa, Yuji Yonemura, Kenta Murotani, Mami Shimizu, Akira Matsuda, Keiya Ozawa, Shinji Nakao
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study. Blood advances 8 (6) (2024)
Kinuko Mitani, Jong Wook Lee, Jun-Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, Koji Nagafuji, Kensuke Usuki, Nobuhiko Uoshima, Tomoaki Fujisaki, Hiroshi Kosugi, Itaru Matsumura, Ko Sasaki, Masahiro Kizaki, Masashi Sawa, Michihiro Hidaka, Naoki Kobayashi, Satoshi Ichikawa, Yuji Yonemura, Kenta Murotani, Mami Shimizu, Akira Matsuda, Keiya Ozawa, Shinji Nakao
Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study. Blood advances (2023)

Nobuhiko Uoshima.css-eqlu8i{font-size:small;padding-left:4px;}